Analysis of essential pathways for self-renewal in common marmoset embryonic stem cells  by Nii, Takenobu et al.
FEBS Open Bio 4 (2014) 213–219journal homepage: www.elsevier .com/locate / febsopenbioAnalysis of essential pathways for self-renewal in common marmoset
embryonic stem cellshttp://dx.doi.org/10.1016/j.fob.2014.02.007
2211-5463/ 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Abbreviations: AKT, protein kinase B; bFGF, basic ﬁbroblast growth factor; CM,
common marmoset; EB, embryoid body; EpiSCs, epiblast stem cells; ERK, extracel-
lular signal-regulated kinase; ESCs, embryonic stem cells; FCM, ﬂow cytometry;
iPSCs, induced pluripotent stem cells; JAK, janus kinase; KSR, knockout serum
replacement; LIF, leukemia inhibitory factor; MEFs, mouse embryonic ﬁbroblasts;
MEK, mitogen-activated protein/extracellular signal-regulated kinase kinase; PI3K,
phosphatidylinositol-3-kinase; RT-PCR, reverse transcription-polymerase chain
reaction; SMAD2/3, mothers against decapentaplegic homolog 2/3; STAT3, signal
transducer and activator of transcription 3; TGFb, transforming growth factor b
⇑ Corresponding author at: Division of Molecular and Clinical Genetics, Medical
Institute of Bioregulation, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka
812-8582, Japan. Tel.: +81 92 642 6434; fax: +81 92 642 6444.
E-mail address: taniken@bioreg.kyushu-u.ac.jp (K. Tani).
1 The ﬁrst two authors contributed equally to this work.Takenobu Nii a,1, Tomotoshi Marumoto a,b,1, Hirotaka Kawano a, Saori Yamaguchi a, Jiyuan Liao a,
Michiyo Okada a, Erika Sasaki c,d, Yoshie Miura a, Kenzaburo Tani a,b,⇑
aDivision of Molecular and Clinical Genetics, Medical Institute of Bioregulation, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
bDepartment of Advanced Molecular and Cell Therapy, Kyushu University Hospital, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
cCentral Institute for Experimental Animals, Kawasaki, Kanagawa 216-0001, Japan
dKeio Advanced Research Center, Keio University School of Medicine, Tokyo 160-8582, Japan
a r t i c l e i n f o a b s t r a c tArticle history:
Received 21 November 2013
Revised 12 February 2014
Accepted 12 February 2014
Keywords:
Embryonic stem cells
Common marmoset
bFGF
TGFb
Self-renewalCommon marmoset (CM) is widely recognized as a useful non-human primate for disease modeling
and preclinical studies. Thus, embryonic stem cells (ESCs) derived from CM have potential as an
appropriate cell source to test human regenerative medicine using human ESCs. CM ESCs have been
established by us and other groups, and can be cultured in vitro. However, the growth factors and
downstream pathways for self-renewal of CM ESCs are largely unknown. In this study, we found that
basic ﬁbroblast growth factor (bFGF) rather than leukemia inhibitory factor (LIF) promoted CM ESC
self-renewal via the activation of phosphatidylinositol-3-kinase (PI3K)-protein kinase B (AKT) path-
way on mouse embryonic ﬁbroblast (MEF) feeders. Moreover, bFGF and transforming growth factor
b (TGFb) signaling pathways cooperatively maintained the undifferentiated state of CM ESCs under
feeder-free condition. Our ﬁndings may improve the culture techniques of CM ESCs and facilitate
their use as a preclinical experimental resource for human regenerative medicine.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Human regenerative medicine, including transplantation of var-
ious functional cells differentiated from embryonic stem cells
(ESCs) or induced pluripotent stem cells (iPSCs), is considered to
have great potential for treating various incurable diseases, and
has thus attracted much public attention. However, preclinical
studies using animal disease models are required to evaluate the
efﬁcacy and safety of ESC/iPSC-derived cells prior to their clinicalapplication. Common marmoset (CM, Callithrixjacchus) has re-
cently been recognized as a useful non-human primate for such
studies, because of its small size, high reproductive capacity, and
genetic similarity to humans [1].
Understanding themolecularmechanisms governing the self-re-
newal of ESCs is important for the development of technologies to
differentiate them into functional cells. Although both human and
mouse ESCs are able to self-renew on feeder cells in vitro,
their growth factor requirements for self-renewal are different.
Basic ﬁbroblast growth factor (bFGF), which activates phosphatidyl-
inositol-3-kinase (PI3K)-protein kinase B (AKT) [2,3] and
mitogen-activated protein/extracellular signal-regulated kinase ki-
nase (MEK)-extracellular signal-regulated kinase (ERK) pathways
[2–8], and transforming growth factor b (TGFb) leading to the acti-
vation of mothers against decapentaplegic homolog 2/3 (SMAD2/3)
[2,6–11], maintain the self-renewal of human ESCs and mouse
epiblast stem cells (EpiSCs). Conversely, in mouse ESCs, leukemia
inhibitory factor (LIF), which activates janus kinase (JAK)-signal
transducer and activator of transcription 3 (STAT3) and PI3K-AKT
pathways, is known to play important roles in maintaining
self-renewal [12–14].
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[15–17]. However, the growth factors used in the culture medium
are different among reports [15,17–21]. Thus, the most appropriate
growth factor and its downstream pathway for maintaining the
self-renewal of CM ESCs still remain to be determined.
In the present study, we characterized two CM ESC cell lines,
Cj11 and CM40, and found that CM ESCs were more similar to hu-
man ESCs rather than mouse ESCs in terms of their growth factor
requirement and molecular signaling pathways for self-renewal.
2. Materials and methods
2.1. CM ESC culture on mouse embryonic ﬁbroblasts (MEFs)
CM ESC lines, CM40 and Cj11, were maintained in CM ESC med-
iumas described before [15]with orwithout 1:1000 LIF (Wako, Osa-
ka, Japan), 5 ng/ml bFGF (PeproTech, NJ, USA), 5 lM PD0325901
(MEK inhibitor, Wako) or 10 lM LY294002 (PI3K inhibitor, Santa
Cruz Biotechnology, CA, USA). CM40 cell line was established in
our laboratory [15], and Cj11 cell line was obtained fromWiCell Re-
search Institute [16]. MEFs were prepared from 13.5 dpc embryos
from ICR mice (Charles River, Japan) using established procedures
[22].
2.2. CM ESC culture under feeder-free conditions
CM40 and Cj11 ESC lines were cultured on Matrigel (BD Biosci-
ences, CA, USA)-coated dishes in Essential 8 medium (Life Technol-
ogies, NY, USA) or Essential 6 medium (Life Technologies) with or
without 1:1000 LIF (Wako), 100 ng/ml bFGF (PeproTech), 2 ng/ml
TGFb (PeproTech), 5 lM PD0325901 (MEK inhibitor, Wako),
10 lM LY294002 (Santa Cruz Biotechnology).
2.3. CM ESC differentiation
Undifferentiated ESCs were detached from the feeder cells by
treatment with 0.25% trypsin (NacalaiTesque, Kyoto, Japan) for
1 min. The collected colonies were processed for embryoid body
(EB) formation assay in CM ESC medium on low cell-binding 12-
well plates (Nalge Nunc International KK, Japan) for 4 or 8 days.
Detailed protocols to differentiate CM ESCs into three germ layers
are described in ‘‘Supplementary Materials and Methods’’.
2.4. Immunocytochemistry
Cells were ﬁxed in 4% paraformaldehyde (PFA)/phosphate-buf-
fered saline (PBS) (NacalaiTesque), permeabilized with 0.3% Triton
X-100/PBS, blocked with staining buffer (2% fetal bovine serum
(FBS)/PBS). The primary antibodies used are shown in Supplemen-
tary Table 1. Nucleiwere counterstainedwithDAPI. Imageswere ob-
tained under a ﬂuorescence microscope (Axiovert 135M; Carl Zeiss,
Germany, or BZ-9000; Keyence) and then analyzed by Axiovert soft-
ware (Carl Zeiss) or BZ-Analyzer software (Keyence).
2.5. Flow cytometry (FCM)
CM ESCs were ﬁxed in 4% PFA/PBS, permeabilized with 0.3% Tri-
ton X-100/PBS, blocked with staining buffer (2% FBS/PBS), and then
incubated with an anti-OCT3/4 antibody (Santa Cruz Biotechnol-
ogy, sc-5279 or sc-8628). The cells were detected on a FACSVerse
ﬂow cytometer (Becton Dickinson, USA), followed by data analysis
using FlowJo software (Tomy Digital Biology, Japan).
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated using an RNeasy Mini Kit (Qiagen, USA),
and cDNA was synthesized using Superscript III reversetranscriptase (Life Technologies). Then PCR was carried out using
the synthesized cDNA as templates and gene-speciﬁc primers
(see Supplemental Table 2). The primers were designed based on
different exons to span the intervening intron and avoid ampliﬁca-
tion of contaminating genomic DNA.
2.7. Western blotting
Cells were incubated on ice with RIPA buffer containing prote-
ase inhibitors (Complete Mini, EDTA-free; Roche, Basel, Switzer-
land) and a phosphatase inhibitor cocktail (NacalaiTesque). The
cell lysates were then resolved by SDS-polyacrylamide gel electro-
phoresis, followed by immunoblotting. The primary antibodies
used are shown in Supplementary Table 3. The signals were de-
tected using a LAS3000 (Fujiﬁlm, Japan). Band intensities were
measured by ImageJ software (NIH).
2.8. Statistical analysis
Unless otherwise noted, inter-group differences were analyzed
using analysis of variance (ANOVA) followed by the Tukey’s post-
hoc test with GraphPad Prism 5 (GraphPad Software, CA, USA).
3. Results
3.1. bFGF promotes self-renewal of CM ESCs on feeder cells
bFGF and LIF have been reported to be essential for the mainte-
nance of human and mouse ESCs, respectively [3,12–14,23–27],
and either or both of these growth factors were considered to be
required for the maintenance of CM ESCs. To determine the opti-
mal condition for culturing CM ESCs, we ﬁrst examined the expres-
sion of receptors for bFGF (FGFR1, FGFR2, FGFR3, and FGFR4) and
LIF (LIFR and gp130). RT-PCR analysis demonstrated that all of
these receptors were expressed in the CM ESCs (Fig. 1A), suggest-
ing that both growth factors play important roles in the biology
of CM ESCs.
In culture, ESCs are generally known to spontaneously differenti-
ate. However, the addition of appropriate growth factors inhibits
such spontaneous differentiation. To evaluate the effects of bFGF
and LIF on the proliferation and differentiation of CM ESCs in vitro,
we passaged CMESCs at a ratio of 1:3 every three days for three pas-
sages, and then counted the numbers of undifferentiated OCT3/4+
cells. We found that the proportion of OCT3/4+ cells was unchanged
regardless of the addition of bFGF or LIF (Fig. 1B). However, the num-
bers of OCT3/4+ cells were signiﬁcantly increased by the addition of
bFGF, but not LIF, comparedwith those of controls culturedwithout
bFGF and LIF (Fig. 1C). Similar results were obtained when the cells
were cultured for more than ten passages (Supplementary Fig. S1
and data not shown). The above experiments were performed using
CM40 cell line, and similar results were obtained with Cj11 cell line
(Supplementary Fig. S2). These results strongly suggest that bFGF
promotes the proliferation of CM ESCs rather than maintaining the
undifferentiated state of CM ESCs.3.2. bFGF-PI3K-AKT pathway supports self-renewal of CM ESCs on
feeder cells
bFGF and its downstream PI3K-AKT and MEK-ERK pathways are
important for the self-renewal of human ESCs [2,3,5,6]. We there-
fore examined whether these pathways were activated by bFGF for
CM ESC self-renewal on feeder cells. CM ESCs were cultured over-
night in medium lacking knockout serum replacement (KSR) and
any growth factors. Then, we added bFGF (5 ng/ml), and examined
the activation of AKT and ERK1/2 in the cells by Western blotting.
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Fig. 1. bFGF promotes self-renewal of CM ESCs in the presence of feeder support. (A) RT-PCR analysis showing the expression of FGFR1, FGFR2, FGFR3, FGFR4, LIFR, and gp130
genes in CM ESCs (CM40). (B) No effect of bFGF on the proportion of OCT3/4+ cells. CM ESCs (CM40; 1.4  105) were seeded on mitomycin C (MMC)-treated MEFs and cultured
with LIF (open square), bFGF (open circle), or without growth factors (control; open triangle). The percentage of OCT3/4+ cells was determined by FCM. (C) Enhancement of
undifferentiated CM ESC growth by bFGF. CM ESCs (CM40; 1.4  105) were seeded on mitomycin C (MMC)-treated MEFs and cultured with LIF (open square), bFGF (open
circle), or without growth factors (control; open triangle). The number of cells was then counted by trypan blue exclusion. The number of OCT3/4+ cells was determined by
multiplying the number of cells by the percentage of OCT3/4+ cells and the passage ratio together. Data are shown as the mean ± SD (n = 4). ⁄⁄P < 0.01 (bFGF vs. control) and 
P < 0.01 (bFGF vs. LIF). Note that all of PCR in (A) was performed with 30 cycles, and no bands were detected for FGFR expression in MEFs in (A), however, they were faintly
done when PCR was performed with 40 cycles.
T. Nii et al. / FEBS Open Bio 4 (2014) 213–219 215The results showed that the band intensity of phosphorylated AKT
was signiﬁcantly increased after the treatment with bFGF, while
that of phosphorylated ERK1/2 was not changed (Fig. 2A and B).
These data suggested that PI3K-AKT, but not MEK-ERK, pathway
was activated by bFGF in CM ESCs under feeder-dependent culture
condition.
Next, to examine whether bFGF-PI3K-AKT pathway plays any
roles in the maintenance of self-renewal of CM ESCs, the cells were
cultured in medium containing bFGF in the presence or absence of
the PI3K inhibitor, LY294002. We found that the proportion of
OCT3/4+ cells was maintained at approximately 90% for at least
three passages when the cells were cultured without LY294002,
whereas it was gradually decreased when the cells were cultured
with LY294002 (day0, 96.75 ± 2.83% vs. day9, 57.97 ± 16.76%,
Fig. 2C). In addition, OCT3/4+ cell proliferation was inhibited in
the presence of LY294002 (day9, bFGF, 7.61 ± 1.59106 cells vs.
bFGF+LY294002, 2.36 ± 1.25106 cells, Fig. 2D). Additionally, even
when bFGF was not added, the proportion of OCT3/4+ cells was sig-
niﬁcantly reduced by the treatment with LY294002 (Fig. 2C), indi-
cating that PI3K-AKT pathway is activated by unknown factors
from MEFs and play roles for self-renewal of CM ESCs. Overall,
these results strongly suggest that bFGF-PI3K-AKT pathway is
essential for the self-renewal of CM ESCs under feeder-dependent
culture condition.
To examine the expression of OCT3/4, we used an antibody
against amino acids 1–134 of human OCT3/4 (monoclonal
OCT3/4 antibody, sc-5279) that was known to be useful for
detecting the expression of CM OCT3/4 [28]. And recent study re-
ported that another antibody raised against amino acids 1–19 of
human OCT3/4 (polyclonal OCT3/4 antibody, sc-8628) was more
useful to detect ESC-speciﬁc OCT3/4 [29]. Thus we performedimmunocytochemistry and FCM analysis using sc-8628, and
obtained the similar results (Supplementary Fig. S3).
3.3. bFGF and TGFb signaling cooperate to maintain the
undifferentiated state of CM ESCs under feeder-free conditions
All of the experiments described above were performed with
feeder support. Thus, the various secreted factors including cyto-
kines and adhesion molecules might have affected the results. To
examine the dependency of CM ESCs on feeder cells, CM ESCs were
cultured on a high or low density of feeder cells, and then the
undifferentiated state was examined by immunocytochemistry
using an anti-NANOG antibody (Supplementary Fig. S1). We found
that CM ESCs on low-density feeder cells lost their expression of
NANOG after four passages, whereas those on high-density feeder
cells maintained NANOG expression even after ten passages
(Supplementary Fig. S1). Therefore, it is conceivable that the
self-renewal of CM ESCs is maintained by unknown factors derived
from feeder cells.
Chen et al. showed that Essential 8 medium (Dulbecco’s modi-
ﬁed Eagle’s medium/F12 supplemented with L-ascorbic acid-2-
phosphate magnesium, insulin, transferrin, sodium selenium,
NaHCO3, bFGF, and TGFb) supports the self-renewal of human ESCs
and iPSCs under feeder-free conditions [30]. To clarify the essential
growth factors required for maintaining the undifferentiated state
of CM ESCs, CM ESCs were cultured under feeder-free condition.
We found that CM ESCs could be cultured on Matrigel in Essential
8 medium without feeder support, although they could not be
maintained for more than three passages (data not shown). Next,
we cultured CM ESCs on Matrigel in Essential 6 medium lacking
bFGF and TGFb overnight, and then the activation of signaling
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Fig. 2. bFGF-PI3K-AKT pathway supports self-renewal of CM ESCs. (A) Western blot analysis showing the activation of AKT by bFGF in CM ESCs. CM40 cells were starved of
bFGF and KSR overnight, and then stimulated with 5 ng/ml of bFGF for the indicated durations. AKT, ERK1/2 and a-Tubulin are shown as loading controls. The relative band
intensities of p-AKT/AKT and p-ERK/ERK are shown in (B). Band intensities were measured by ImageJ software. Data are shown as the mean ± SD. The Student’s t-test was
used to test inter-group differences. ⁄⁄P < 0.01. (C) Inhibition of self-renewal by LY294002. CM ESCs (CM40; 1.4  105) were seeded on MMC-treated MEFs and cultured in
medium containing bFGF (open circle), control medium (open triangle), bFGF+LY294002 (closed circle) or LY294002 (closed triangle). The percentage of OCT3/4+ cells was
then determined by FCM at the indicated day as shown in (C). The number of live cells was counted by trypan blue exclusion. Growth curves were generated by multiplying
the number of live cells by the percentage of OCT3/4+ cells and passage ratio together as shown in (D). Data are shown as the mean ± SD. bFGF, n = 4; control, n = 4;
bFGF+LY294002, n = 3; LY294002, n = 3; ⁄P < 0.05, ⁄⁄P < 0.01, and ⁄⁄⁄P < 0.005, bFGF vs. control; P < 0.01 and P < 0.005, bFGF+LY294002 or LY294002 vs. control.
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AKT, bFGF-MEK-ERK, TGFb-SMAD2/3, and LIF-JAK-STAT3 path-
ways) were analyzed by Western blotting after the addition of
bFGF, TGFb, or LIF to the medium. We found that phosphorylation
of AKT and ERK was increased by the addition of bFGF, while it was
decreased by the treatment with LY294002 or PD0325901, sug-
gesting that both of AKT and ERK were activated downstream of
bFGF under feeder-free condition (Fig. 3A and B). And the addition
of TGFb resulted in an increase of phosphorylated SMAD2/3
(Fig. 3A and B), suggesting that SMAD2/3 was activated down-
stream of TGFb. Moreover, the addition of LIF resulted in an in-
crease of phosphorylated STAT3, suggesting that STAT3 was
activated downstream of LIF (Supplementary Figs. S4B and D).
These results suggested that bFGF-PI3K-AKT, bFGF-MEK-ERK,
TGFb-SMAD2/3 and LIF-JAK-STAT3 pathways known to regulate
self-renewal of human or mouse ESCs were activated in CM ESCs
under feeder-free condition. It should be noted that ERK was not
activated by 5 ng/ml of bFGF that was used for the culture on fee-
der cells as described in Fig. 2A and B (Supplementary Fig. S4B), but
it was remarkably activated by 100 ng/ml of bFGF generally used
for feeder-free culture of human ESCs (Fig. 3A and B) [30].
Next, to determine the growth factors maintaining the undiffer-
entiated state of CM ESCs under feeder-free condition, CM ESCs
were cultured in the feeder-free system with various combinations
of growth factors, followed by analysis of their undifferentiated
state morphologically and immunocytochemically. Most of the col-
onies cultured in Essential 6 medium with bFGF, bFGF+TGFb,
bFGF+LIF, or bFGF+TGFb+LIF showed a well-packed appearance,
and a majority of the cells expressed NANOG (Fig. 3C). In contrast,
most of the colonies cultured in Essential 6 mediumwith TGFb, LIF,
or TGFb+LIF showed an unpacked appearance, and a majority of the
cells did not express NANOG (Fig. 3C). Moreover, NANOG+ and
well-packed colonies were found at the highest proportion(98.00 ± 0.88%) when the cells were cultured in the presence
of TGFb+bFGF (Fig. 3D). In addition, almost all of the colonies
were positive for OCT3/4, SOX2, SSEA-4, TRA1-60 and TRA1-81
(Supplementary Fig. S3), and these colony forming cells kept the
capability of differentiating three lineages (Supplementary
Fig. S5). This observation indicates that the addition of both TGFb
and bFGF is the most appropriate growth factor combination for
maintenance of the undifferentiated state of CM ESCs under
feeder-free condition, which is similar to a characteristic of
human ESCs [2,6,9–11].
3.4. CM ESCs show phenotypes similar to those of human ESCs and
mouse EpiSCs
Human ESCs and mouse EpiSCs share a number of similar phe-
notypes as shown in Table 1 [7,8]. CM ESCs formed ﬂattened colo-
nies and expressed NANOG as well as markers for both mouse
EpiSCs and human ESCs, such as T, CER1, EOMES, FOXA2, GATA6,
and SOX17 (Supplementary Figs. S1 and S6A) [7]. Moreover, bFGF
and TGFb signalings play crucial roles in maintaining the undiffer-
entiated state of human ESCs and mouse EpiSCs [2,7,8,11,30], and
the same roles of these signaling pathways were also found in CM
ESCs (Fig. 3C and D).
Previous reports have shown that apoptosis of human ESCs and
mouse EpiSCs is induced by culturing after complete dissociation
[31,32].Watanabeet al. showedthatdissociation-inducedapoptosis
of human ESCs is suppressed by treatment with the Rho-associated
kinase (ROCK) inhibitor Y27632 [33]. To examine whether dissocia-
tion-induced apoptosis of human ESCs andmouse EpiSCs was simi-
larly found in CM ESCs, colonies of CM ESCs were dissociated into
single cells by trypsinization, and then the cells were plated on
Matrigel-coated disheswith orwithout Y27632. Comparedwith un-
treated controls, we found that Y27632-treated CM ESCs produced
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apoptosis of CM ESCs occurred and was suppressed by Y27632
(Supplementary Figs. S6B and S6C). Thus, we concluded that CM
ESCs are similar to human ESCs and mouse EpiSCs.4. Discussion
Recent advances in the ﬁeld of basic research for pluripotent
stem cells such as the generation of ESCs, iPSCs and stimulus-trig-
Table 1
The characters of mouse EpiSCs and mouse, human and CM ESCs.
Mouse ESCs Mouse EpiSCs Human ESCs CM ESCs
Morphology of colony Small, dome Large, ﬂat Large, ﬂat Large, ﬂat
Growth factor dependency LIF +   
bFGF  + + +
TGFb/activin  + + +
Marker expression NANOG + + + +
OCT3/4 + + + +
T (brachyury)  + + +
CER1  + + +
EOMES  + + +
FOXA2  + + +
GATA6  + + +
SOX17  + + +
Tolerance to single cell dissociation +   
Contribution in chimera +  N/D N/D
N/D = not determined.
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tic expectations for human regenerative medicine [22,34–38]. And
the need for the development of methods to test new therapeutic
approach using such cells is increasing. CM is a useful experimental
animal that can suit such needs, and therefore, the characterization
of CM ESCs is important. In this study, we investigated essential
signaling pathways for the self-renewal of CM ESCs under feeder-
dependent and feeder-free culture conditions.
LIF has been widely used to establish and maintain non-human
primate ESCs [15,17,18,39–42], although some researchers claim
that LIF cannot maintain the self-renewal capacity of these cells
[16,41–43]. We found that LIF did not affect the capacity for
self-renewal of CM ESCs (Figs. 1 and 3), although it activated the
JAK-STAT3 pathway (Supplementary Fig. S3). More extensive stud-
ies are needed to further explore the roles of the LIF-JAK-STAT3
pathway in CM ESCs. In our previous report, the expression of LIFR
was not found in undifferentiated CM ESCs [15], but it was found in
this study after repetitive experiments (Fig. 1A). This discrepancy
was considered to be caused by the detection threshold of
RT-PCR under different conditions, particularly PCR primers used
in our previous report were human LIFR sequence-originated
because there were no available marmoset genomic sequence data.
We also found that the self-renewal of CM ESCs cultured on fee-
der cells was remarkably promoted by bFGF, which is similar to the
characteristic of human ESCs (Fig. 1). However, even in the absence
of bFGF, most CM ESCs could be maintained in an undifferentiated
state by culture on feeder cells, although they showed slower
growth compared to those cultured in bFGF containing medium
(Fig. 1B and C). This observation indicates that growth factors se-
creted from feeder cells such as activin, noggin and bFGF, maintain
the undifferentiated state of CM ESCs [44,45]. Indeed, CM ESC col-
onies cultured on low-density feeder cells differentiated within
four passages (Supplementary Fig. S1).
Previous studies have demonstrated the critical roles of PI3K-
AKT and MEK-ERK pathways in the self-renewal of human ESCs
[2–6]. Our results showed that AKT, but not ERK1/2, was activated
by the addition of bFGF (5 ng/ml), while ERK1/2 was continuously
activated even in the absence of bFGF on feeder support (Fig. 2A).
Moreover, inhibition of either MEK-ERK or PI3K-AKT pathways re-
sulted in reduced self-renewal of CM ESCs (Fig. 2 and Supplemen-
tary Fig. S7). Therefore, activation of the PI3K-AKT pathway
downstream of bFGF as well as the MEK-ERK pathway by unknown
mechanisms is required for self-renewal of CM ESCs on feeder sup-
port. On the other hand, both AKT and ERK1/2 were activated by
the addition of bFGF (100 ng/ml) under feeder-free condition
(Fig. 3A and B). And treatment with LY294002 resulted in the
elevated expression of endoderm and mesoderm markers, andtreatment with PD0325901 caused the reduced expression of these
markers, indicating that modulation of these pathways affects
the differentiation process in CM ESCs (Supplementary Fig. S8).
We are now extensively investigating the effect of these inhibitors
on the differentiation process of CM ESCs induced by the treatment
with speciﬁc cytokines and EB formation assay.
Several studies have demonstrated differences in the mecha-
nisms of ESC self-renewal between mice and humans. Mouse ESCs
require LIF for their self-renewal, whereas human ESCs require
bFGF and TGFb. Mouse EpiSCs originating from post-implantation
embryos depend on bFGF and TGFb, and show characteristics sim-
ilar to those of human ESCs originating from the inner cells mass of
blastocysts as shown in Table 1 [7,8,10]. Mouse EpiSCs are there-
fore considered to be the counterpart of human ESCs. In this study,
we demonstrated that CM ESCs were very similar to human ESCs
and mouse EpiSCs in terms of their morphology, gene expression,
growth factor dependency for self-renewal, and vulnerability to
single cell dissociation.
Our ﬁndings strongly suggest that CM ESCs are phenotypically
similar to human ESCs. Therefore, CM ESCs may facilitate the
development of valuable preclinical experimental systems to test
new therapeutic modalities for incurable human diseases, particu-
larly in the ﬁeld of regenerative medicine.
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